Signaling Pathways - Clk - constitutive androstane receptor (CAR) - AP-1 - RET
清除全部
-
B7468 CITCO1 CitationTarget: constitutive androstane receptor (CAR)Summary: 组成型雄激素受体（CAR）激动剂 -
B4664 T-522410 CitationTarget: AP-1|MMPSummary: C-Fos/AP-1抑制剂 -
B3707 ML167Target: ClkSummary: Clk4抑制剂 -
A2174 Lenvatinib (E7080)中文名: 乐伐替尼，仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂 -
A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂 -
A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂 -
A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂 -
N1846 Tanshinone IIA中文名: 丹参酮IIATarget: AP-1|MAGLSummary: 抗氧化和抗炎剂 -
N1831 Luteolin中文名: 木犀草素，四羟黄酮Target: AP-1|MMP|15-lipoxygenasesSummary: 抗氧化剂和自由基清除剂